Aditya Birla Sun Life AMC Q1 Results FY27: PAT at Rs 29 Cr for June 2026 Quarter

The Aditya Birla Sun Life AMC Q1 results FY27 show consolidated revenue of Rs 2,045 Cr for the quarter ended 30 June 2026, +11.15% from Rs 1,840 Cr in Q1 FY26, as Aditya Birla Sun Life AMC reported its numbers on 1 August 2026.

Aditya Birla Sun Life AMC posted a net profit (PAT) of Rs 29 Cr for the quarter, against Rs 24 Cr a year earlier. Shares traded around Rs 94.6 on the NSE, down 0.07% on the day, as investors weighed the print against trends in the pharmaceuticals sector. Here is a full breakdown of the financial highlights, key business factors, dividend status, outlook and risks.

Click Here – Get Free Investment Predictions

Aditya Birla Sun Life AMC Q1 Results FY27 Financial Highlights

The table below summarises Aditya Birla Sun Life AMC's consolidated numbers for the quarter against the year ago period.

Metric	Q1 FY27 (Jun 2026)	Q1 FY26 (Jun 2025)	YoY Change
Revenue	Rs 2,045 Cr	Rs 1,840 Cr	+11.15%
Gross Profit	Rs 103 Cr	Rs 90 Cr	+14.73%
Gross Profit Margin	5.0%	4.9%	+0.1 pts
Net Profit (PAT)	Rs 29 Cr	Rs 24 Cr	+20.62%
Net Profit Margin	1.4%	1.3%	+0.1 pts

Aditya Birla Sun Life AMC Q1 FY27 Performance Analysis

Revenue growth was the standout number for the quarter. Sales rose +11.15% year on year to Rs 2,045 Cr, up from Rs 1,840 Cr in the year ago period, as demand held firm through the June quarter.

Profitability improved alongside the topline. Gross profit grew +14.73% year on year to Rs 103 Cr (5.0% margin), outpacing revenue growth and pointing to better cost control or a richer product mix during the quarter.

The bottom line followed through on the operating performance. Net profit increased +20.62% year on year to Rs 29 Cr, up from Rs 24 Cr in Q1 FY26, translating the quarter's operating trends into a stronger PAT print.

Check the Univest Screener for Live Data

Aditya Birla Sun Life AMC Q1 FY27: Key Business Factors

1. Revenue Growth Trajectory

Aditya Birla Sun Life AMC reported revenue of Rs 2,045 Cr for the June 2026 quarter against Rs 1,840 Cr in the year ago period, a change of +11.15%. This pace of change is a primary swing factor behind the quarter's numbers, and investors typically track whether it holds up in the following quarters.

2. Gross Margin and Cost Trends

Gross profit moved from Rs 90 Cr in Q1 FY26 to Rs 103 Cr in Q1 FY27, a change of +14.73%. In the pharmaceuticals sector, this line is sensitive to raw material and API cost volatility, regulatory approvals and pricing pressure in key markets, and this quarter's numbers reflect how Aditya Birla Sun Life AMC managed that balance.

3. Bottom Line and Earnings Quality

Net profit moved from Rs 24 Cr in Q1 FY26 to Rs 29 Cr this quarter, up +20.62%. On a reported basis this is the figure that flows through to earnings per share, and it is usually the first number investors check.

Dividend Details

Specific dividend information was not confirmed as part of this results snapshot. Investors should check the official exchange filing on the NSE or BSE website, or track the Univest Screener, for the latest dividend announcement, record date and payment date from Aditya Birla Sun Life AMC.

Aditya Birla Sun Life AMC Outlook for FY27

This quarter sets the tone for the rest of FY27. If the growth in revenue and improvement in net profit persist, analysts are likely to revisit their FY27 estimates for Aditya Birla Sun Life AMC. Investors should also watch input costs and demand trends in the pharmaceuticals sector through the year.

Aditya Birla Sun Life AMC Stock Performance After the Results

Aditya Birla Sun Life AMC shares traded around Rs 94.6 on the NSE, down 0.07% around the time the results were in focus. The 52 week trading range was not confirmed as part of this snapshot; investors can check the live 52 week high and low, along with technical levels, on the Univest Screener before making any trading decision.

Download the Univest iOS App or Univest Android App to track Aditya Birla Sun Life AMC live share price and upcoming quarterly results.

Key Risks

Investors reading through Aditya Birla Sun Life AMC's numbers should also weigh the following risks.

1. Margin and Input Cost Risk

Being in the pharmaceuticals sector, Aditya Birla Sun Life AMC remains exposed to raw material and API cost volatility, regulatory approvals and pricing pressure in key markets. A reversal in the trend seen this quarter could pressure margins in coming quarters.

2. Execution and Working Capital Risk

Execution risk around working capital, receivables and order timelines can cause quarter to quarter volatility in reported numbers, so this quarter's trends should be read over a few quarters rather than in isolation.

3. Macro and Sector Risk

Broader macro factors including interest rates, currency movements and demand cycles in the pharmaceuticals sector could influence how sustainable this quarter's trends prove to be over FY27.

Conclusion

The Aditya Birla Sun Life AMC Q1 results FY27 show revenue of Rs 2,045 Cr and Rs 29 Cr for the quarter, against Rs 1,840 Cr and Rs 24 Cr in Q1 FY26. Revenue growth and a stronger bottom line were the two moving parts this quarter. Investors tracking Aditya Birla Sun Life AMC should watch the next few quarters for confirmation of this trend and consult a SEBI-registered advisor before making investment decisions based on these numbers.

Frequently Asked Questions on Aditya Birla Sun Life AMC Q1 Results FY27

When were the Aditya Birla Sun Life AMC Q1 results FY27 announced?

Ans. They reflect the quarter ended 30 June 2026, with the data reported as of 1 August 2026. Investors should confirm the exact board meeting date from the official NSE or BSE filing.

What is the PAT in Aditya Birla Sun Life AMC's Q1 FY27 results?

Ans. The PAT stood at Rs 29 Cr, compared with Rs 24 Cr in Q1 FY26, a change of +20.62%.

What was the revenue in Aditya Birla Sun Life AMC's Q1 FY27 results?

Ans. Revenue came in at Rs 2,045 Cr for the quarter, a change of +11.15%, compared with Rs 1,840 Cr in Q1 FY26.

Did Aditya Birla Sun Life AMC declare a dividend with the Q1 FY27 results?

Ans. Dividend details were not confirmed as part of this results snapshot. Check the latest exchange filing on NSE or BSE, or the Univest Screener, for confirmation.

What is the outlook for Aditya Birla Sun Life AMC after Q1 FY27?

Ans. Analysts will track whether the growth in revenue and improvement in profit continue into the September 2026 quarter, along with input cost and demand trends in the pharmaceuticals sector.

How did the stock react to Aditya Birla Sun Life AMC's Q1 FY27 results?

Ans. Shares traded around Rs 94.6 on the NSE, down 0.07% as the numbers came into focus.

Is Aditya Birla Sun Life AMC a good buy after the Q1 FY27 results?

Ans. The quarter shows a net profit of Rs 29 Cr on revenue of Rs 2,045 Cr. This article is for educational purposes only and is not investment advice. Consult a SEBI-registered advisor before making any investment decision.